Pranlukast (BioDeep_00000033329)
human metabolite blood metabolite Chemicals and Drugs
代谢物信息卡片
N-[4-oxo-2-(2H-1,2,3,4-tetrazol-5-yl)-4H-chromen-7-yl]-4-(4-phenylbutoxy)benzamide
化学式: C27H23N5O4 (481.17499580000003)
中文名称: 普鲁司特
谱图信息:
最多检出来源 Homo sapiens(blood) 92.86%
分子结构信息
SMILES: C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC4=C(C=C3)C(=O)C=C(O4)C5=NNN=N5
InChI: InChI=1S/C27H23N5O4/c33-23-17-25(26-29-31-32-30-26)36-24-16-20(11-14-22(23)24)28-27(34)19-9-12-21(13-10-19)35-15-5-4-8-18-6-2-1-3-7-18/h1-3,6-7,9-14,16-17H,4-5,8,15H2,(H,28,34)(H,29,30,31,32)
描述信息
Pranlukast is only found in individuals that have used or taken this drug. It is a cysteinyl leukotriene receptor-1 antagonist. It antagonizes or reduces bronchospasm caused, principally in asthmatics, by an allergic reaction to accidentally or inadvertently encountered allergens.Pranlukast selectively antagonizes leukotriene D4 (LTD4) at the cysteinyl leukotriene receptor, CysLT1, in the human airway. Pranlukast inhibits the actions of LTD4 at the CysLT1 receptor, preventing airway edema, smooth muscle contraction, and enhanced secretion of thick, viscous mucus.
同义名列表
数据库引用编号
6 个数据库交叉引用编号
- PubChem: 115100
- HMDB: HMDB0015481
- ChEMBL: CHEMBL1085767
- Wikipedia: Pranlukast
- chemspider: 102999
- CAS: 103177-37-3
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Alexandre P Rogerio, Fernanda F Anibal. Role of leukotrienes on protozoan and helminth infections.
Mediators of inflammation.
2012; 2012(?):595694. doi:
10.1155/2012/595694. [PMID: 22577251] - H Hirata, M Arima, Y Fukushima, K Honda, K Sugiyama, T Tokuhisa, T Fukuda. Over-expression of the LTC4 synthase gene in mice reproduces human aspirin-induced asthma.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
2011 Aug; 41(8):1133-42. doi:
10.1111/j.1365-2222.2011.03720.x. [PMID: 21429049] - H Taki, K Shinoda, H Hounoki, R Ogawa, S Ishizawa, E Sugiyama, K Tobe. Serum interleukin-5 levels correlate with disease activity of Churg-Strauss syndrome in a patient treated with a leucotriene receptor antagonist, pranlukast, and inhaled corticosteroid.
Scandinavian journal of rheumatology.
2010 Aug; 39(4):341-3. doi:
10.3109/03009740903270573. [PMID: 20560805] - Masamichi Okubo, Hiroki Yamanaka, Kimiko Kobayashi, Koichi Noguchi. Leukotriene synthases and the receptors induced by peripheral nerve injury in the spinal cord contribute to the generation of neuropathic pain.
Glia.
2010 Apr; 58(5):599-610. doi:
10.1002/glia.20948. [PMID: 19908283] - Yoko Yamakawa, Yoshikazu Ohtsuka, Kiyotaka Ohtani, Tohru Fujii, Satoru Nagata, Yuichiro Yamashiro, Toshiaki Shimizu. Effects of leukotriene receptor antagonists on peripheral eosinophil counts and serum IgE levels in children with food allergy.
Drugs in R&D.
2010; 10(3):147-54. doi:
10.2165/11586150-000000000-00000. [PMID: 20945945] - Hironori Sagara, Tatsuo Yukawa, Ryuichi Kashima, Takenori Okada, Takeshi Fukuda. Effects of pranlukast hydrate on airway hyperresponsiveness in non-asthmatic patients with Japanese cedar pollinosis.
Allergology international : official journal of the Japanese Society of Allergology.
2009 Jun; 58(2):277-87. doi:
10.2332/allergolint.08-oa-0058. [PMID: 19390239] - Graziano Riccioni, Alessandra Zanasi, Nicola Vitulano, Barbara Mancini, Nicolantonio D'Orazio. Leukotrienes in atherosclerosis: new target insights and future therapy perspectives.
Mediators of inflammation.
2009; 2009(?):737282. doi:
10.1155/2009/737282. [PMID: 20150962] - Cláudia Savassi Guimaraes, Natalie Moulton-Levy, Allen Sapadin, Claudia Vidal. Kimura's Disease.
Case reports in medicine.
2009; 2009(?):424053. doi:
10.1155/2009/424053. [PMID: 19718429] - Susumu Nakade, Akinori Yamauchi, Junji Komaba, Tomoya Ohno, Junsaku Kitagawa, Naoki Honda, Chihiro Hasegawa, Kazuhiro Yoneda, Yasuo Kodama, Kuninobu Yasuda, Junichi Azuma, Yasuyuki Miyata. Effect of clarithromycin on the pharmacokinetics of pranlukast in healthy volunteers.
Drug metabolism and pharmacokinetics.
2008; 23(6):428-33. doi:
10.2133/dmpk.23.428. [PMID: 19122337] - Takuto Mizoe, Tetsuya Ozeki, Hiroaki Okada. Preparation of drug nanoparticle-containing microparticles using a 4-fluid nozzle spray drier for oral, pulmonary, and injection dosage forms.
Journal of controlled release : official journal of the Controlled Release Society.
2007 Sep; 122(1):10-5. doi:
10.1016/j.jconrel.2007.06.001. [PMID: 17655963] - John J Lima. Treatment heterogeneity in asthma: genetics of response to leukotriene modifiers.
Molecular diagnosis & therapy.
2007; 11(2):97-104. doi:
10.1007/bf03256228. [PMID: 17397245] - Takahiko Horiguchi, Soichi Tachikawa, Rieko Kondo, Junichi Miyazaki, Mamoru Shiga, Masahiro Hirose, Kashin Kobayashi, Nobuyuki Hayashi, Daisuke Ohira, Toshinori Nasu, Yoichiro Otake, Hideharu Hata. Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma.
Arzneimittel-Forschung.
2007; 57(2):87-91. doi:
10.1055/s-0031-1296588. [PMID: 17396618] - Kazutaka Tokita, Yasuhiro Uchida, Tetsuro Yamamoto. Roles of leukocytosis and cysteinyl leukotriene in polymorphonuclear leukocyte-dependent plasma extravasation.
Journal of leukocyte biology.
2006 Dec; 80(6):1308-19. doi:
10.1189/jlb.0805488. [PMID: 16940329] - Fumiaki Yamashita, Hisakazu Ohtani, Noriko Koyabu, Fumihiko Ushigome, Hiroki Satoh, Hideyasu Murakami, Takeshi Uchiumi, Takanori Nakamura, Michihiko Kuwano, Masayuki Tsujimoto, Yasufumi Sawada. Inhibitory effects of angiotensin II receptor antagonists and leukotriene receptor antagonists on the transport of human organic anion transporter 4.
The Journal of pharmacy and pharmacology.
2006 Nov; 58(11):1499-505. doi:
10.1211/jpp.58.11.0011. [PMID: 17132213] - Hideaki Shirasaki, Etsuko Kanaizumi, Nobuhiko Seki, Megumi Kikuchi, Kazumasa Watanabe, Nobuhiro Konno, Tetsuo Himi. Distribution of specific binding sites for cysteinyl leukotriene 1 receptor antagonist in human nasal mucosa.
Acta oto-laryngologica.
2006 Sep; 126(9):948-51. doi:
10.1080/00016480500540493. [PMID: 16864492] - M Peters-Golden, M M Gleason, A Togias. Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
2006 Jun; 36(6):689-703. doi:
10.1111/j.1365-2222.2006.02498.x. [PMID: 16776669] - Susumu Nakade, Shinya Ueda, Tomoya Ohno, Kazuki Nakayama, Yasuyuki Miyata, Eiji Yukawa, Shun Higuchi. Population pharmacokinetics of pranlukast hydrate dry syrup in children with allergic rhinitis and bronchial asthma.
Drug metabolism and pharmacokinetics.
2006 Apr; 21(2):133-9. doi:
10.2133/dmpk.21.133. [PMID: 16702733] - Liaman Mamedova, Valérie Capra, Maria Rosa Accomazzo, Zhan-Guo Gao, Silvia Ferrario, Marta Fumagalli, Maria P Abbracchio, G Enrico Rovati, Kenneth A Jacobson. CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors.
Biochemical pharmacology.
2005 Dec; 71(1-2):115-25. doi:
10.1016/j.bcp.2005.10.003. [PMID: 16280122] - Toshishige Shibamoto, Zonghai Ruan, Sen Cui, Wei Liu, Yasutaka Kurata. Involvement of platelet-activating factor and leukotrienes in anaphylactic segmental venoconstriction in ovalbumin sensitized guinea pig livers.
Prostaglandins & other lipid mediators.
2005 Dec; 78(1-4):218-30. doi:
10.1016/j.prostaglandins.2005.08.003. [PMID: 16303618] - Jun Kato, Tadashi Kohyama, Hitoshi Okazaki, Masashi Desaki, Takahide Nagase, Stephen I Rennard, Hajime Takizawa. Leukotriene D4 potentiates fibronectin-induced migration of human lung fibroblasts.
Clinical immunology (Orlando, Fla.).
2005 Nov; 117(2):177-81. doi:
10.1016/j.clim.2005.07.003. [PMID: 16109507] - Kyung S Lee, So R Kim, Hee S Park, Gong Y Jin, Yong C Lee. Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression.
The Journal of allergy and clinical immunology.
2004 Nov; 114(5):1093-9. doi:
10.1016/j.jaci.2004.07.039. [PMID: 15536415] - Yasutomo Nakanishi, Takeshi Nabe, Nobuaki Mizutani, Hiroshi Takenaka, Shigekatsu Kohno. Synergism between cysteinyl leukotrienes and thromboxane A2 to induce allergic late phase nasal blockage in guinea pigs.
Prostaglandins & other lipid mediators.
2004 Oct; 74(1-4):125-37. doi:
10.1016/j.prostaglandins.2004.07.006. [PMID: 15560121] - Y Tsuji, Y Abe, M Hisano, T Sakai. Urinary leukotriene E4 in Henoch-Schonlein purpura.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
2004 Aug; 34(8):1259-61. doi:
10.1111/j.1365-2222.2004.02029.x. [PMID: 15298567] - Ahmed M Hamad, Amy M Sutcliffe, Alan J Knox. Aspirin-induced asthma: clinical aspects, pathogenesis and management.
Drugs.
2004; 64(21):2417-32. doi:
10.2165/00003495-200464210-00004. [PMID: 15482000] - Takahiko Horiguchi, Rieko Kondo, Junici Miyazaki, Mamoru Shiga, Masahiro Sugiyama, Masahiro Hirose, Soichi Tachikawa. [Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma].
Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.
2003 Oct; 41(10):696-703. doi:
NULL. [PMID: 14584388] - Anna M Feldweg, Daniel S Friend, Joseph S Zhou, Yoshihide Kanaoka, Massoud Daheshia, Lin Li, K Frank Austen, Howard R Katz. gp49B1 suppresses stem cell factor-induced mast cell activation-secretion and attendant inflammation in vivo.
European journal of immunology.
2003 Aug; 33(8):2262-8. doi:
10.1002/eji.200323978. [PMID: 12884301] - James P Kemp. Recent advances in the management of asthma using leukotriene modifiers.
American journal of respiratory medicine : drugs, devices, and other interventions.
2003; 2(2):139-56. doi:
10.1007/bf03256645. [PMID: 14720013] - Takahiko Horiguchi, Soichi Tachikawa, Rieko Kondo, Mamoru Shiga, Masahiro Hirose, Tomohiro Ito. Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma.
Arzneimittel-Forschung.
2003; 53(10):714-21. doi:
10.1055/s-0031-1299817. [PMID: 14650364] - Takeshi Terashima, Kazuhisa Amakawa, Akiko Matsumaru, Kazuhiro Yamaguchi. Correlation between cysteinyl leukotriene release from leukocytes and clinical response to a leukotriene inhibitor.
Chest.
2002 Nov; 122(5):1566-70. doi:
10.1378/chest.122.5.1566. [PMID: 12426254] - Kenji Baba, Ayako Sakakibara, Takeo Yagi, Sayaka Niwa, Hideo Wakayama, Kenzo Takagi. Long-term observations of the clinical course after step down of corticosteroid inhalation therapy in adult chronic asthmatics: correlation with serum levels of eosinophil cationic protein.
Respirology (Carlton, Vic.).
2002 Sep; 7(3):255-66. doi:
10.1046/j.1440-1843.2002.00389.x. [PMID: 12153692] - T Nabe, K Yamashita, M Miura, T Kawai, S Kohno. Cysteinyl leukotriene-dependent interleukin-5 production leading to eosinophilia during late asthmatic response in guinea-pigs.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
2002 Apr; 32(4):633-40. doi:
10.1046/j.0954-7894.2002.01329.x. [PMID: 11972613] - Yasushi Obase, Terufumi Shimoda, Shin-ya Tomari, Kazuko Mitsuta, Tetsuya Kawano, Hiroto Matsuse, Shigeru Kohno. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients.
Chest.
2002 Jan; 121(1):143-50. doi:
10.1378/chest.121.1.143. [PMID: 11796443] - Y Obase, T Shimoda, S Tomari, K Mitsuta, C Fukushima, T Kawano, H Matsuse, S Kohno. Effects of pranlukast on aspirin-induced bronchoconstriction: differences in chemical mediators between aspirin-intolerant and tolerant asthmatic patients.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
2001 Jul; 87(1):74-9. doi:
10.1016/s1081-1206(10)62328-9. [PMID: 11476469] - M Hashimoto, T Fujishima, H Tanaka, H Kon, T Saikai, A Suzuki, M Nakatsugawa, S Abe. Churg-Strauss syndrome after reduction of inhaled corticosteroid in a patient treated with pranlukast for asthma.
Internal medicine (Tokyo, Japan).
2001 May; 40(5):432-4. doi:
10.2169/internalmedicine.40.432. [PMID: 11393418]